Testing at scale is needed, but that's not enough.
I wrote an oped on how we can use our digital infrastructure to guide us on the unchartered exit-ramp and avoid a 2nd wave rebound
washingtonpost.com/opinions/2020/… 1/x
![](https://pbs.twimg.com/media/EVVPxXwU8AAVElj.png)
There are clever ways to use smartphones for tracing contacts; we don't have enough people to do that! 6/x
blog.google/inside-google/…
![](https://pbs.twimg.com/media/EVVcAoWUwAItymm.jpg)
![](https://pbs.twimg.com/media/EVVcCq_UUAAmfSu.jpg)
Testing for infection and/or antibody cannot be considered as a real time surveillance tool. At best, it is a one-off, not continuous metric
9/x
![](https://pbs.twimg.com/media/EVVivKHUwAE7jp9.jpg)